Gyre Therapeutics (GYRE) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.81% |
| Dec 31, 2025 | 300.78% |
| Sep 30, 2025 | 26.60% |
| Jun 30, 2025 | 78.70% |
| Mar 31, 2025 | -10.58% |
| Dec 31, 2024 | 139.24% |
| Sep 30, 2024 | 1,381.25% |
| Jun 30, 2024 | 45.45% |
| Mar 31, 2024 | -99.84% |
| Dec 31, 2023 | 6,924.49% |
| Sep 30, 2023 | 10.11% |
| Jun 30, 2023 | -57.62% |
| Mar 31, 2023 | -98.29% |
| Dec 31, 2022 | 5,382.59% |
| Sep 30, 2022 | -35.26% |
| Jun 30, 2022 | -32.82% |
| Mar 31, 2022 | -24.60% |
| Dec 31, 2021 | -4.21% |
| Sep 30, 2021 | -27.47% |
| Jun 30, 2021 | -4.19% |
| Mar 31, 2021 | 11.52% |
| Dec 31, 2020 | -13.86% |
| Sep 30, 2020 | 28.06% |
| Jun 30, 2020 | 3.60% |
| Mar 31, 2020 | 19.97% |
| Dec 31, 2019 | -16.23% |
| Sep 30, 2019 | -11.30% |
| Jun 30, 2019 | 8.93% |
| Mar 31, 2019 | 12.03% |
| Dec 31, 2018 | 5.41% |
| Sep 30, 2018 | 27.40% |
| Jun 30, 2018 | -9.08% |
| Mar 31, 2018 | 97.39% |
| Dec 31, 2017 | -5.54% |
| Sep 30, 2017 | 192.79% |
| Jun 30, 2017 | -7.50% |
| Mar 31, 2017 | -7.69% |
| Dec 31, 2016 | -30.85% |
| Sep 30, 2016 | 13.94% |
| Jun 30, 2016 | 7.84% |
| Mar 31, 2016 | -19.90% |
| Dec 31, 2015 | 267.31% |
| Sep 30, 2015 | 26.83% |
| Jun 30, 2015 | -6.82% |
| Mar 31, 2015 | -20.00% |
| Dec 31, 2014 | -1.79% |
| Sep 30, 2014 | -87.93% |
| Jun 30, 2014 | -43.76% |
| Mar 31, 2014 | 121.38% |
| Dec 31, 2013 | -665.84% |
| Sep 30, 2013 | 4.12% |
| Jun 30, 2013 | -59.42% |
| Mar 31, 2013 | 17.13% |
| Dec 31, 2012 | 55.01% |
| Sep 30, 2012 | -56.99% |
| Jun 30, 2012 | 7.88% |
| Mar 31, 2012 | -4.30% |
| Dec 31, 2011 | 121.22% |
| Sep 30, 2011 | -4.03% |
| Jun 30, 2011 | -56.40% |
| Mar 31, 2011 | 75.28% |
| Dec 31, 2010 | 97.76% |
| Sep 30, 2010 | 26.57% |